MECOLZINE

This brand name is authorized in Cyprus, Ecuador, Malta

Active ingredients

The drug MECOLZINE contains one active pharmaceutical ingredient (API):

1 Mesalazine UNII 4Q81I59GXC - MESALAMINE

Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. Read about Mesalazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MECOLZINE Suppository	Web Search	MPI, EU: SmPC
MECOLZINE Gastro-resistant tablet	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07EC02	Mesalazine	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EC Aminosalicylic acid and similar agents
Discover more medicines within A07EC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2659-MEE-0417
Country: MT	Medicines Authority	Identifier(s): MA1278/00101, MA1278/00102, MA1278/00301, MA1278/00302